Skip to main content
Livermore
Livermore
ZHEN

Anavex Life Sciences Corp.

AVXL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001314052

No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Anavex Life Sciences Corp. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AVXL: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1272136+11
Shares21.6M40020.6M−1.01M (−4.7%)
Value$492.2M$10.0K$370.1M−$122.2M (−24.8%)

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Anavex Life Sciences Corp. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AVXL in Q3 2021
InstitutionSharesValue% of portfolio
Pier Capital, LLC276,183$4.96M0.51%
Nomura Holdings Inc150,000$2.69M0.02%
Kestra Private Wealth Services, LLC100,300$1.80M0.10%
ACT Capital Management, LLC70,500$1.26M0.66%
Miracle Mile Advisors, LLC61,656$1.11M0.05%
ExodusPoint Capital Management, LP35,342$634.0K0.01%
Cetera Advisor Networks LLC31,074$558.0K0.01%
Old Mission Capital LLC30,366$545.0K0.02%
Ergoteles LLC28,600$513.0K0.02%
HAP Trading, LLC27,871$500.0K0.04%
SG Americas Securities, LLC25,206$452.0K0.00%
Investors Financial Group, LLC24,000$431.0K0.23%
Quantitative Investment Management, LLC21,436$384.0K0.03%
CIBC World Markets Inc.15,737$282.0K0.00%
Trexquant Investment LP15,255$274.0K0.02%
AlphaCrest Capital Management LLC14,400$258.0K0.01%
Alpine Global Management, LLC12,548$225.0K0.05%
Victory Capital Management Inc11,810$212.0K0.00%
Cresset Asset Management, LLC10,554$190.0K0.00%
Teacher Retirement System of Texas10,124$182.0K0.00%
Point72 Hong Kong Ltd3,581$64.0K0.00%
Cahill Financial Advisors Inc3,500$63.0K0.01%
Cutler Group LP2,500$44.0K0.00%
FinTrust Capital Advisors, LLC2,425$44.0K0.01%
North Star Investment Management Corp.1,000$18.0K0.00%
Harbour Investments, Inc.300$5.00K0.00%
TCI Wealth Advisors, Inc.194$3.00K0.00%
US Bancorp27$00.00%

Sold out (17)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of AVXL in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Great Lakes Advisors, LLC679,703$15.5M
First Trust Advisors LP177,823$4.07M
EAM Investors, LLC177,728$4.06M
EAM Global Investors LLC120,803$2.76M
Virtu Financial LLC81,011$1.85M
Caption Management, LLC73,000$1.67M
SEI Investments Co69,645$1.60M
Federated Hermes, Inc.35,527$812.0K
Tudor Investment Corp Et Al33,481$765.0K
ProShare Advisors LLC16,100$368.0K
Barclays PLC12,768$292.0K
Paloma Partners Management Co12,033$275.0K
Keystone Wealth Partners9,950$227.0K
Panagora Asset Management Inc8,457$193.0K
Advisory Services Network, LLC5,700$130.0K
Kessler Investment Group, LLC3,000$69.0K
Farmers & Merchants Investments Inc121$3.00K

Not filed for Q3 2021 yet (2)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVXL in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC200$5.00K
Horan Securities, Inc.200$5.00K